Sanford Laboratories for Innovative Medicines is an independent, not-for-profit collaborative hub focused on the research and maturation of next-generation RNA technologies and therapies. The organization was launched in 2023 to catalyze partnerships between academia and industry, enabling efficient prototyping of multiple new RNA-based medicines in parallel while leveraging complementary strengths of both sectors.
2021
87-3910792
$12 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Sanford Labs is at the forefront of RNA-based therapies, revolutionizing the drug development process.
Become part of our innovative team dedicated to improving patient outcomes through RNA innovations.
Our mission is to unlock the therapeutic potential of RNA for various diseases.
Overall Score
43
12
/100
Program Expense Ratio
0.00%
2
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.8346
4
/20
Working Capital Ratio
125.5
2
/20
Fundraising Efficiency
0
2
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 2M | 99.95% |
Program Services | 0 | 0.00% |
Investment Income | 1.082K | 0.05% |
Sales of Non-Inventory Assets | 0 | 0.00% |
Other Notable Sources | 0 | 0.00% |
Total Revenue | 2.001M | 100.00% |
Arts & Culture
Arts & Culture ResearchArts & Culture
Arts & Culture ResearchArts & Culture
Arts & Culture ResearchArts & Culture
Arts & Culture ResearchArts & Culture
Arts & Culture Research